A Window of Opportunity Study to Characterize the Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics of CPX-POM in Patients with Newly Diagnosed or Recurrent Bladder Tumors

Brief Summary

Type:
Bladder

Study Type:
Other

Phase:
Feasibility/Pilot

ClinicalTrials.gov Identifier:
NCT04525131

Study #:
STUDY00146182

Start Date:
Nov 24, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04525131

View Complete Trial Details & Eligibility at ClinicalTrials.gov